Showing results (31-40 of 274) with videos related to
Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committeeS Percy Ivy, Lillian L Siu, Elizabeth Garrett-Mayer, et al.Cancer|December 15, 2023
Top advances of the year: Ovarian cancerMelissa A Lumish, Elise C Kohn, William P TewProteomics|October 24, 2007
Constitution and quantity of lysis buffer alters outcome of reverse phase protein microarraysMary Winters, Bhavana Dabir, Minshu Yu, et al.Drug Discovery Today|September 11, 2007
The ongoing evolution of proteomics in malignancyAmit S Dhamoon, Elise C Kohn, Nilofer S AzadAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Gynecologic Cancers: Emerging Novel Strategies for Targeting DNA Repair DeficiencyRebecca S Kristeleit, Rowan E Miller, Elise C KohnAmerican Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|June 15, 2005
Applying proteomics in clinical trials: assessing the potential and practical limitations in ovarian cancerNana E Tchabo, Meghan S Liel, Elise C KohnThe Lancet. Oncology|August 16, 2021
Effect of removing race from glomerular filtration rate-estimating equations on anticancer drug dosing and eligibility: a retrospective analysis of National Cancer Institute phase 1 clinical trial participantsMorgan A Casal, S Percy Ivy, Jan H Beumer, et al.Journal of Proteomics|June 22, 2010
Proteomics and ovarian cancer: integrating proteomics information into clinical careJohn L Hays, Geoffrey Kim, Iulia Giuroiu, et al.Cancer|June 23, 2015
Ovarian cancer treatment: The end of empiricism?Stephanie Lheureux, Katherine Karakasis, Elise C Kohn, et al.Current Pharmaceutical Design|February 7, 2003
Calcium as a molecular target in angiogenesisAngela M Patton, Jareer Kassis, Howard Doong, et al.Pageof 28